Zhejiang Shenghua Biok Biology Co Ltd (600226) — Cash Flow-to-Debt Ratio
Zhejiang Shenghua Biok Biology Co Ltd (600226) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥77.05 Million could theoretically repay 0% of its total liabilities (CN¥1.24 Billion) in one year. See Zhejiang Shenghua Biok Biology Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shenghua Biok Biology Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Zhejiang Shenghua Biok Biology Co Ltd across 27 annual periods. Also explore Zhejiang Shenghua Biok Biology Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shenghua Biok Biology Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Zhejiang Shenghua Biok Biology Co Ltd. For market capitalisation and broader financial context, see market value of Zhejiang Shenghua Biok Biology Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | CN¥-31.31 Million | CN¥1.08 Billion | ▲ +68.8% |
| 2023 | -0.09x | CN¥-76.70 Million | CN¥826.05 Million | ▼ -184.8% |
| 2022 | 0.11x | CN¥25.22 Million | CN¥230.38 Million | ▼ -70.0% |
| 2021 | 0.36x | CN¥105.27 Million | CN¥288.64 Million | ▲ +230.6% |
| 2020 | 0.11x | CN¥46.54 Million | CN¥421.83 Million | ▲ +187.3% |
| 2019 | -0.13x | CN¥-78.22 Million | CN¥619.05 Million | ▲ +47.2% |
| 2018 | -0.24x | CN¥-176.12 Million | CN¥735.73 Million | ▼ -463.6% |
| 2017 | 0.07x | CN¥82.29 Million | CN¥1.25 Billion | ▲ +298.0% |
| 2016 | -0.03x | CN¥-55.29 Million | CN¥1.66 Billion | ▼ -139.2% |
| 2015 | 0.08x | CN¥69.19 Million | CN¥816.58 Million | ▲ +206.7% |
| 2014 | 0.03x | CN¥24.42 Million | CN¥884.11 Million | ▼ -78.8% |
| 2013 | 0.13x | CN¥119.28 Million | CN¥916.13 Million | ▼ -53.2% |
| 2012 | 0.28x | CN¥217.96 Million | CN¥782.86 Million | ▲ +336.2% |
| 2011 | 0.06x | CN¥57.58 Million | CN¥902.06 Million | ▼ -57.4% |
| 2010 | 0.15x | CN¥133.16 Million | CN¥887.98 Million | ▲ +34.8% |
| 2009 | 0.11x | CN¥93.01 Million | CN¥836.27 Million | ▼ -67.0% |
| 2008 | 0.34x | CN¥309.13 Million | CN¥916.34 Million | ▲ +199.2% |
| 2007 | 0.11x | CN¥112.75 Million | CN¥999.98 Million | ▼ -51.5% |
| 2006 | 0.23x | CN¥184.32 Million | CN¥793.49 Million | ▲ +5.3% |
| 2005 | 0.22x | CN¥169.95 Million | CN¥770.72 Million | ▼ -4.9% |
| 2004 | 0.23x | CN¥101.61 Million | CN¥438.24 Million | ▼ -38.7% |
| 2003 | 0.38x | CN¥99.44 Million | CN¥262.80 Million | ▼ -12.5% |
| 2002 | 0.43x | CN¥80.83 Million | CN¥187.01 Million | ▲ +23.1% |
| 2001 | 0.35x | CN¥57.56 Million | CN¥163.93 Million | ▼ -17.1% |
| 2000 | 0.42x | CN¥47.14 Million | CN¥111.31 Million | ▼ -44.8% |
| 1999 | 0.77x | CN¥28.87 Million | CN¥37.60 Million | ▲ +105.1% |
| 1998 | 0.37x | CN¥31.39 Million | CN¥83.86 Million | — |